OCSpring24_01

PARP Inhibitors in Prostate Cancer: Practical Application of Recent Advances to Ensure Equitable Care in Rural and Underserved Populations

Date

April 13, 2024

Explore related products in the following collection:

Oncology Congress - Apr 2024

Speakers

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Neeraj Agarwal, MD, FASCO

Director, Genitourinary Oncology Program, NCICCC Huntsman Cancer Institute, University of Utah

Related Products

Thumbnail for Advances in HER2-Mutant NSCLC: Optimizing Outcomes in Rural and Underserved Communities

Advances in HER2-Mutant NSCLC: Optimizing Outcomes in Rural and Underserved Communities

Thumbnail for From Conference to Community: Advancing Equity in Multiple Myeloma Care and Treatment

From Conference to Community: Advancing Equity in Multiple Myeloma Care and Treatment

Thumbnail for Optimizing Risk Stratification and Management of Myelodysplastic Syndrome: Strategies for Improving Equitable Access to Care in Rural and Underserved Communities

Optimizing Risk Stratification and Management of Myelodysplastic Syndrome: Strategies for Improving Equitable Access to Care in Rural and Underserved Communities

Thumbnail for TROP2-Targeted Antibody-Drug Conjugates in NSCLC: An Update for Oncologists Who Serve Patients in Rural and Underserved Communities

TROP2-Targeted Antibody-Drug Conjugates in NSCLC: An Update for Oncologists Who Serve Patients in Rural and Underserved Communities